NASDAQ:MCRB | EBITDA | Seres Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30-$20.6M
2026-03-31-$20.13M
2025-12-31-$18.42M
2025-09-30-$21.43M
2025-06-30-$23.82M
2025-03-31-$26.16M
2024-12-31-$27.75M
2024-09-30-$27.77M
2024-06-30-$27.45M
2024-03-31-$32.88M
2023-12-31-$35.39M
2023-09-30-$42.9M
2023-06-30$51.05M
2023-03-31-$69.17M
2022-12-31-$104,000.00
2022-09-30-$57.36M
2022-06-30-$61.64M
2022-03-31-$54.18M
2021-12-31-$47.88M
2021-09-30$69.9M
2021-06-30-$46.72M
2021-03-31-$33.85M
2020-12-31-$16.39M
2020-09-30-$28.42M
2020-06-30-$18.85M
2020-03-31-$17.89M
2019-12-31-$17.39M
2019-09-30-$15.31M
2019-06-30-$9.03M
2019-03-31-$22.55M
2018-12-31-$19.68M
2018-09-30-$20.24M
2018-06-30-$26.18M
2018-03-31-$26.33M
2017-12-31-$27.87M
2017-09-30-$5.45M
2017-06-30-$26.66M
2017-03-31-$24.16M
2016-12-31-$23.98M
2016-09-30-$17.84M
2016-06-30-$27.27M
2016-03-31-$19.53M
2015-12-31-$19.45M
2015-09-30-$14.38M
2015-06-30-$12.22M
2015-03-31-$12.25M
2014-12-31-$7.14M
2014-09-30-$3.53M
2014-06-30-$2.58M

Annual EBITDA

DateEBITDA
2025-12-31-$89.84M
2024-12-31-$115.85M
2023-12-31-$188.85M
2022-12-31-$173.29M
2021-12-31-$58.55M
2020-12-31-$81.55M
2019-12-31-$64.27M
2018-12-31-$92.42M
2017-12-31-$84.14M
2016-12-31-$88.63M
2015-12-31-$54.13M
2014-12-31-$14.89M
2013-12-31-$5.96M